Letermovir vs. high-dose valacyclovir for cytomegalovirus prophylaxis following haploidentical or mismatched unrelated donor allogeneic hematopoietic cell transplantation receiving post-transplant cyclophosphamide. uri icon

authors

  • Freyer, Craig W
  • Hexner, Elizabeth O
  • Luger, Selina M
  • Mangan, James K
  • Martin, Mary Ellen
  • Shannon R. McCurdy, MD
  • Perl, Alexander E
  • Porter, David L
  • Pratz, Keith
  • Smith, Jacqueline
  • Stadtmauer, Edward A
  • Carulli, Alison
  • Loren, Alison W
  • Gier, Shannon
  • Ganetsky, Alex
  • Timlin, Colleen
  • Schuster, Mindy
  • Babushok, Daria
  • Frey, Noelle V
  • Gill, Saar I

publication date

  • February 20, 2022